☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Grant
EMA to Grant Initial Authorization to Gilead's Remdesivir for COVID-19 is Imminent
May 18, 2020
Amgen and its Foundation Grant $12.5M to Support COVID-19 Relief Efforts Globally
March 24, 2020
PharmaMar's Lurbinectedin Granted as Orphan drug designation by U.S. FDA for Small Cell Lung Cancer(SCLC)
August 3, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
